Meghan V. Joyce Guardant Health, Inc. (GH) insider trading activity

Meghan V. Joyce is Director of Guardant Health, Inc.. Currently has a direct ownership of 7,780 shares of GH, which is worth approximately $335,629. The most recent transaction as insider was on Apr 04, 2025, when has been sold 66 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.78K

1.29% 3M change

69.57% 12M change

Total Value Held $335,629

Meghan V. Joyce Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 04 2025	BUY Exercise of conversion of derivative security	-	66 Added 0.84%	7,780 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	67 Added 0.86%	7,714 Common Stock
Mar 03 2025	SELL Open market or private sale	$4,271 $42.71 p/Share	100 Reduced 1.29%	7,647 Common Stock
Feb 04 2025	BUY Exercise of conversion of derivative security	-	66 Added 0.84%	7,747 Common Stock
Jan 04 2025	BUY Exercise of conversion of derivative security	-	66 Added 0.85%	7,681 Common Stock
Dec 04 2024	BUY Exercise of conversion of derivative security	-	67 Added 0.87%	7,615 Common Stock
Dec 02 2024	SELL Open market or private sale	$3,590 $35.9 p/Share	100 Reduced 1.31%	7,548 Common Stock
Nov 13 2024	SELL Open market or private sale	$86,590 $29.9 p/Share	2,896 Reduced 27.47%	7,648 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	-	66 Added 0.62%	10,544 Common Stock
Oct 04 2024	BUY Exercise of conversion of derivative security	-	66 Added 0.63%	10,478 Common Stock
Sep 04 2024	BUY Exercise of conversion of derivative security	-	67 Added 0.64%	10,412 Common Stock
Aug 04 2024	BUY Exercise of conversion of derivative security	-	66 Added 0.63%	10,345 Common Stock
Jul 04 2024	BUY Exercise of conversion of derivative security	-	66 Added 0.64%	10,279 Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	-	5,592 Added 35.38%	10,213 Common Stock
Jun 04 2024	SELL Open market or private sale	$2,787 $27.87 p/Share	100 Reduced 2.12%	4,621 Common Stock
Jun 04 2024	BUY Exercise of conversion of derivative security	-	67 Added 1.4%	4,721 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	66 Added 1.4%	4,654 Common Stock
Apr 04 2024	BUY Exercise of conversion of derivative security	-	67 Added 1.44%	4,588 Common Stock
Mar 04 2024	SELL Open market or private sale	$1,905 $19.05 p/Share	100 Reduced 2.16%	4,521 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	-	66 Added 1.41%	4,621 Common Stock
Feb 04 2024	BUY Exercise of conversion of derivative security	-	66 Added 1.43%	4,555 Common Stock
Jan 04 2024	BUY Exercise of conversion of derivative security	-	67 Added 1.47%	4,489 Common Stock
Dec 04 2023	SELL Open market or private sale	$2,634 $26.34 p/Share	100 Reduced 2.21%	4,422 Common Stock
Dec 04 2023	BUY Exercise of conversion of derivative security	-	66 Added 1.44%	4,522 Common Stock
Nov 04 2023	BUY Exercise of conversion of derivative security	-	66 Added 1.46%	4,456 Common Stock

Also insider at

OSCR

Oscar Health, Inc. Healthcare

Chief Operating Officer

SAM

BOSTON BEER CO INC Consumer Defensive

MVJ

Meghan V. Joyce

Director

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account